This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Safety and Efficacy of the Apexum Ablator

Sponsored by Apexum Ltd.

About this trial

Last updated 16 years ago

Study ID

Apexum Trial

Status

Unknown status

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 19 years ago

What is this trial about?

The study is designed to test the hypothesis that there is a difference in healing kinetics and healing rate between teeth treated by conventional endodontic procedure alone and those in which such procedure was supplemented with the Apexum Ablator protocol

What are the participation requirements?

Yes

Inclusion Criteria

1. Subject is > 18 years old

2. Subject has periapical lesion(s) associated with root canal infection in one or more roots that have a single root canal per root. These may include upper and lower single rooted incisors, canines or premolars, as well as roots of multi-rooted teeth, providing that they have a single root canal per root. These may include distal roots of lower molars, palatal and disto-buccal roots of upper molars

3. Lesion mean diameter: 3-6 mm, PAI score 4 or 5

4. Roots with mature fully formed apices

No

Exclusion Criteria

1. Previous root canal filling

2. Roots with abnormal root canal morphology

3. Roots with more than one root canal per root, as either evident from the pre-operative radiographs or as discovered during initiation of the root canal treatment

4. A tooth that remained symptomatic after the first and when needed a second session of the root canal treatment (remained with an excessive sensitivity to percussion, persistent sinus tract, persistent exudate in the root canal etc.)

5. Un-restorable teeth

6. Significant periodontal pockets

7. Lack of cortical bone around the lesion, as judged clinically

8. Active acute infection - cellulites, abcess

9. Proximity of anatomical structures to the periapical lesion to the extent that Apexum Ablator enucleation procedure may damage or otherwise jeopardize these structures. Such anatomical structures may include the maxillary sinus, the nasal cavity, the inferior alveolar nerve and its canal, the mental nerve or any other structure that may be jeopardized by the procedure

10. Subject with:

- Uncontrolled systemic hypertension
- Severe uncontrolled Diabetes Mellitus
- Current steroid therapy in excess of prednisone 5 mg/day
- Chronic inflammatory oral disease
- HIV positive patients
- Chronic renal failure
- Hematological disease (malignancy, severe anemia, bleeding tendency etc.)
- Osteoporosis, receiving biphosphonates
- Post head and neck irradiation treatment
- In need of endocarditis antibiotic prophylactic treatment [sub acute bacterial endocarditis (SBE]

11. Other severe or life-threatening systemic disease (ASA P3 and above)

Locations

Location

Status

Recruiting
Withdrawn